 
 |
Dr. Ranjit Ray (infectious diseases and immunology) has received a five-year grant for $683,674 from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases. The research will focus on developing a vaccine for the hepatitis C virus.
Frank R. Dunphy, M.D. (hematology and oncology) has received a two-year contract award for $201,200 from Ortho Biotech Inc. Dunphy's study is titled, "Phase III Randomized Trial of Recombinant Human Erythropoietin (r-HuEPO) 'Early' Vs. 'Late' Administration in Patients Treated with Chemotherapy."
Dr. Tomasz Heyduk (biochemistry and molecular biology) has received a four-year grant renewal award for $689,419 from the National Institutes of Health/National Institute of General Medical Sciences. Heyduk's grant title is "Inter and Intramolecular Communications in Transcription."
Dr. Alireza Rezaie (biochemistry and molecular biology) has received a one-year subcontract award for $127,180 from the National Heart, Lung and Blood Institute/Oklahoma Medical Research Foundation. The research will focus on the development of new drugs useful in treating thrombotic (clotting) and hemorrhagic (bleeding) complications.
  |